missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Cell Culture Media, Supplements, and Reagents
  4. Cell Culture Media
  5. Cell Therapy Systems (CTS) Cell Culture Media
  6. Gibco™ CTS™ AIM V™ SFM

Gibco™ CTS™ AIM V™ SFM
GREENER_CHOICE

Catalog No. 0870112DK
Encompass
Change view
Click to view available options
Quantity:
1 L
10 L
2 product options available for selection
Product selection table with 2 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
0870112DK 1 L
0870112BK 10 L
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 2 options available.
2 options
Catalog No. 0870112DK Supplier Gibco™ Supplier No. 0870112DK

Description

CTS AIM V SFM is a defined, serum-free medium (SFM) for the proliferation and/or manipulation of T cells, dendritic cells, and other immune cells manufactured in compliance with cGMP.

Gibco Cell Therapy Systems (CTS) AIM-V SFM is a defined, serum-free medium specifically designed for the proliferation and/or manipulation of T cells, dendritic cells, and other immune cells that is manufactured in compliance with current Good Manufacturing Practice (cGMP) standards.

CTS AIM V SFM contains L-glutamine, 50 μg/mL streptomycin sulfate, and 10 μg/mL gentamicin sulfate.

CTS quality

Gibco CTS products are manufactured at a site that uses methods and controls that conform to cGMP for medical devices, 21 CFR Part 820. Our FDA-registered manufacturing sites are ISO 13485-certified. Gibco CTS products follow USP 'ancillary materials for cell, gene, and tissue-engineered products' within the responsibilities applicable to a supplier.*

Accompanied by documentation to support your regulatory filing

Specific intended-use statements, full documentation traceability, and convenient access to our Drug Master File (DMF) are available.

*Other aspects of USP will be the responsibility of the end-user to assess. Thermo Fisher Scientific cannot fulfill USP in regards to application and therapy-specific aspects (e.g., residual assessment and removal of the Ancillary Material).

Specifications

Cell Type Monocytes, Dendritic Cells, T Cells, Hybridomas, PBMCs, Fibroblasts, Macrophages, Myeloma Cells, Lymphocytes
Classification Animal Origin
Form Liquid
Product Type Cell Culture Medium
Serum Level Serum-free
Sterility Sterile-filtered
For Use With (Application) Cell and Gene Therapy Research, Development, and Manufacturing
Manufacturing Quality ISO 13485, MDSAP, FDA-registered, 21 CFR 820
Quantity 1 L
Shipping Condition Ambient
Format Bottle
Content And Storage Store at 2–8°C and protect from light.
Show More Show Less

Frequently Asked Questions (FAQs)

What is CTS?

The Gibco Cell Therapy Systems (CTS) portfolio of cell and gene therapy products are GMP manufactured, safety tested, and backed by regulatory documentation to support your transition from discovery through clinical and commercial manufacturing. Through our CTS solutions, we are committed to helping customers streamline therapeutic development, minimize risk, and ease the burden on their quality systems. Learn more here.
What is the difference between AIM V Medium (Cat. Nos. 12055083, 12055091) and CTS AIM V SFM (Cat. Nos. 0870112DK, 0870112BK)?

The difference is in the intended usage of the two media. AIM V Medium (Cat. Nos. 12055083, 12055091) is for research use only whereas CTS AIM V SFM (Cat. Nos. 0870112DK, 0870112BK) is for research use or manufacturing of cell, gene, or tissue-based products.
What is the difference between CTS AIM-V Medium and CTS AIM V SFM?

These two media have comparable performance and same cGMP quality. The main difference is that CTS AIM-V Medium (Cat. Nos. A3830801, A3830802, A4672701) does not contain phenol red and antibiotics. This medium formulation has been used as an ancillary reagent in a therapeutic cancer vaccine approved by FDA.

For Research Use or Manufacturing of Cell, Gene, or Tissue-Based Products. CAUTION: Not intended for direct administration into humans or animals.